Type 2 Diabetes Mellitus with Proteinuria

• CLINICAL_TRIALS trial_result · 2012-11-30
  Clinical Trial Update: Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose [Phase 4]

  Phase 4 study assessing whether the calcium channel blocker amlodipine influences serum FGF-23 levels and other clinical/laboratory paramete…